SCHEMBL3582540

SCHEMBL3582540

Cc1c(C)n(Cc2ccccc2)c2c(N(Cc3ccc(F)cc3)C(=O)OC(C)(C)C)ccnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 1/20 0.36
GNRHR P30968 1/20 0.36
FABP4 P15090 1/20 0.36
ENPP2 Q13822 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3582539 0.99 MCL1 (0.40) MCL1MEN1KMT2APOLBGNRHR
SCHEMBL3588704 0.94 ALDH1A1 (0.35) MCL1MEN1KMT2APOLBNR1H4
Hydrochloric Acid SCHEMBL3588700 0.93 ALDH1A1 (0.34) MCL1MEN1KMT2APOLBNR1H4
SCHEMBL3588212 0.92 MAPT (0.36) MCL1MEN1KMT2AENPP2NR1H4
Hydrochloric Acid SCHEMBL3588209 0.91 MCL1 (0.37) MCL1MEN1KMT2AENPP2NR1H4
SCHEMBL3594641 0.91 MAPK1 (0.36) MCL1MEN1KMT2APOLBNR1H4
SCHEMBL3584631 0.91 MEN1 (0.42) MEN1KMT2APOLBLMNAMAPT
Hydrochloric Acid SCHEMBL3594638 0.91 MCL1 (0.36) MCL1MEN1KMT2APOLBNR1H4
Hydrochloric Acid SCHEMBL3584628 0.91 MEN1 (0.42) MEN1KMT2APOLBLMNAMAPT
SCHEMBL3583197 0.89 LMNA (0.41) MEN1KMT2ALMNAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784403-B1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2013-07-17 EP claimed
US-7642269-B2 Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-01-05 US claimed
US-20070213358-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213358-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, PPOX MCL1 4413/4885MEN1 2718/4885KMT2A 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.